Real world evidence for legacy effect of early glycaemic control in type 2 diabetes on risk of macrovascular disease
| Autores principales: | , , , , , |
|---|---|
| Formato: | Conference item |
| Lenguaje: | English |
| Publicado: |
Springer
2017
|
| Sumario: |
|---|